Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,854 | 12,327 | N/A | N/A | N/A |
| Marketable Securities | N/A | 7,323 | N/A | N/A | N/A |
| Other current assets | 14,855 | 0 | 0 | 0 | 6,770 |
| TOTAL | $90,869 | $22,224 | $N/A | $N/A | $6,770 |
| Non-Current Assets | |||||
| PPE Net | 1,175 | 961 | N/A | N/A | N/A |
| Other Non-Current Assets | 246 | 719 | 0 | 0 | 12,250 |
| TOTAL | $1,421 | $1,680 | $N/A | $N/A | $12,250 |
| Total Assets | $92,290 | $23,904 | $N/A | $N/A | $19,020 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 935 | 1,636 | 0 | 0 | 5,030 |
| Accrued Expenses | 9,006 | 3,314 | N/A | N/A | 15,440 |
| Other current liabilities | N/A | N/A | N/A | N/A | 22,580 |
| TOTAL | $22,821 | $4,950 | $N/A | $N/A | $108,410 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,175 | 553 | 0 | 0 | 1,380 |
| TOTAL | $877 | $630 | $N/A | $N/A | $16,100 |
| Total Liabilities | $23,698 | $5,580 | $N/A | $N/A | $124,510 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | N/A | 70 |
| Retained earnings | -131,915 | -91,862 | N/A | N/A | N/A |
| Other shareholders' equity | 185,909 | 108,978 | 0 | 0 | -2,790 |
| TOTAL | $68,592 | $18,324 | $N/A | $N/A | $1,083,090 |
| Total Liabilities And Equity | $92,290 | $23,904 | $0 | $0 | $1,207,600 |